Rotavirus vaccine could fight severe diarrhea in developing countries
January 28th, 2010 - 1:50 pm ICT by ANILondon, Jan 28 (ANI): Rotavirus vaccine, Rotarix, could effectively reduce the overall incidence of severe rotavirus diarrhoea in developing countries, finds a new study.
Rotavirus is the leading cause of severe, acute gastroenteritis among infants and young children throughout the world and is responsible for an estimated 527,000 deaths among children under five each year.
More than 90pc of childhood deaths attributed to rotavirus infection occur in developing countries.
Symptoms include severe diarrhoea and vomiting, leading to loss of fluid and electrolytes which can result in dehydration, shock, and death.
Developed by GlaxoSmithKline Biologicals (GSK), Rotarix was tested in the Phase III clinical trial in Malawi and South Africa, which found that the vaccine reduced the overall incidence of severe rotavirus diarrhoea by 61.2 percent.
Although vaccine efficacy was lower in Malawi (49.4 percent) compared with South Africa (76.9 percent).
The vaccine could prevent more rotavirus diarrhoea episodes in Malawi because of a higher rate of severe disease in the country.
The new data informed a recent global recommendation of rotavirus vaccine by the World Health Organisation (WHO).
“These data show for the first time that rotavirus vaccination can prevent severe diarrhoea in an African setting, where almost half of the total global burden of rotavirus deaths occurs,” said Dr Nigel Cunliffe, Reader in Medical Microbiology at the University of Liverpool, who led the study team in Malawi.
“They demonstrate the large impact that rotavirus vaccines could have in countries with high diarrhoeal disease burden when introduced into their national childhood immunisation schedules,” added Cunliffe
The research is published in the New England Journal of Medicine. (ANI)
- 'Indian infants make 25 percent of global diarrhea deaths' - Mar 09, 2011
- Utilization Of Glaxo's Rotarix Vaccine Discontinued Provisionally - Mar 23, 2010
- National Institute of Immunology is developing anti- diarrhoea vaccine - Jun 12, 2009
- Dr Reddy's ties up with GlaxoSmithKline - Jun 15, 2009
- New anti-malaria vaccine found effective in children - Feb 04, 2010
- Diarrhoea kills 1.5 mn children annually: UN - Oct 15, 2009
- Malaria vaccine could be available by 2011: report - Jun 01, 2009
- New malaria vaccine found safe for children - Feb 06, 2010
- World's largest malaria vaccine trial begins in 7 African countries - Nov 04, 2009
- India capable of producing lower-cost HPV vaccine - Jul 10, 2010
- Pharma firms to conduct H1N1 vaccine human trials in India - Dec 08, 2009
- Soon, an injectable vaccine to help kick the butt - Nov 18, 2009
- Researchers advise wider use of control measures for diarrhoeal disease - Jul 05, 2010
- Malaria vaccine in the offing - Nov 24, 2009
- Swine flu vaccine made by killing sharks - Dec 30, 2009
Tags: acute gastroenteritis, childhood deaths, childhood immunisation, diarrhoea and vomiting, disease burden, dr nigel, england journal of medicine, fluid and electrolytes, glaxosmithkline biologicals, global burden, london jan, medical microbiology, national childhood, new england journal, new england journal of medicine, rotavirus vaccine, rotavirus vaccines, university of liverpool, vaccine efficacy, world health organisation